Recently Featured

Avo Secures $10 Million to Enhance Physician Workflow Efficiency

April 1, 2026
Avo, a startup leveraging patient health records to streamline administrative tasks for physicians, has successfully raised $10 million in funding, as reported exclusively by Endpoints News. This financial boost is aimed at enhancing Avo’s innovative platform, which assists doctors in managing paperwork and making informed decisions during patient visits. The significance of this funding lies…

PRISM ALS: New Stem Cell Models Could Transform Research Into Treatments for MND/ALS

April 1, 2026
A new global initiative launched today aims to close a critical gap in ALS/MND drug discovery – current cell models used for testing treatments do not currently reflect the diverse nature of the disease – that affects both researchers developing therapies and the people urgently waiting for them. The ALS Therapy Development Institute (ALS TDI),…

Symeres & Ambagon Therapeutics Collaborate on Molecular Glue Research in Colorectal Cancer

April 1, 2026
Symeres has recently partnered with Ambagon Therapeutics, a pre-clinical biotechnology company, to explore a new class of small molecules, known as molecular glues, for potential use in colorectal cancer and other hard-to-target diseases. Molecular glues represent an emerging therapeutic modality that enables or stabilizes interactions between proteins, offering an alternative to conventional inhibitors or activators.…

Ongoing Cases